ABSTRACT
Pharmaceutical biotechnology is an emerging field that integrates biology with technological advancement to develop promising solutions to healthcare obstacles. This chapter explores future directions in pharmaceutical biotechnology, focusing on advancements in plant-based systems, microbial innovations, and their synergistic interactions. Plants are a source of chemical compounds, with a broad range of therapeutic properties. Innovations in genetic modification, including CRISPR-Cas9, are efficient in improving phytochemical production, including alkaloids and phenolic compounds. Advanced cultivation techniques, such as hydroponics, also improve plants with higher drug yields. Microbial innovations are transforming drugs. The role of microbes, such as actinomycetes, in the production of novel natural compounds and the use of genetically modified microbes in innovating secondary metabolite production are advancing. Drug development is improving with the advancement of CRISPR-mediated strains. Additionally, the transformation of microbes converts prodrugs into active drugs and encourages stereospecific drug production. Synergistic plant-microbe interactions allow efficient therapeutic technology. Optimized natural product production and symbiotic interactions with bacteria and fungi are producing novel bioactive compounds. Biotransformation of plant-derived compounds by microbes develops more effective pharmaceutical products, while plant-microbe interactions mitigate chemical additives and enhance sustainable drug development. This chapter demonstrates how pharmaceutical biotechnology could change drug discovery, production, and sustainability, establishing the way for a less hazardous future.
